Grufity logoGrufity logo

GMED

71.54USD+0.40(+0.56%)Market Closed

Globus Medical Inc

Market Summary

USD71.54+0.40Market Closed
0.56%

GMED Stock Price

RSI Chart

Valuation

Market Cap

6.7B

Price/Earnings

44.21

Price/Sales

6.87

Price/Cashflow

28.45

MarketCap/EBT

34.53

Price/Sales

Profitability

EBT Margin

19.89%

Return on Equity

8.9%

Return on Assets

7.9%

Fundamentals

Revenue

Revenue (TTM)

998.4M

Revenue Y/Y

10.63%

Revenue Q/Q

-3.6%

Earnings

Earnings (TTM)

151.5M

Earnings Y/Y

0.47%

Earnings Q/Q

-13.11%

Price Action

52 Week Range

52.6081.78
(Low)(High)

Last 7 days

3.7%

Last 30 days

7.1%

Last 90 days

18.6%

Trailing 12 Months

6.9%

Financial Health

Current Ratio

6.1

Investor Care

Buy Backs (1Y)

1.60%

Diluted EPS (TTM)

1.51

Peers (Alternatives to Globus Medical)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
10.2T
429.9M
-10.97% 36.28%
185.5K
28.0K
144.70% 331.94%
86.7B
17.9B
1.82% -7.99%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
9.71% -21.89%
62.6
14.1
11.47% -18.42%
67.1B
18.9B
2.22% 0.83%
38.21
3.25
-6.81% -14.96%
61.8B
12.3B
5.65% 8.48%
69.9
5.01
10.11% 51.89%
43.9B
5.4B
-11.99% -33.30%
30.09
8.18
5.29% -1.25%
MID-CAP
6.7B
998.4M
7.06% 6.92%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
10.81% -24.63%
-331.15
7.96
20.10% -221.96%
3.9B
380.1M
-15.13% 7.13%
-29.57
10.69
18.85% -63.58%
3.6B
790.7M
-29.09% -70.24%
-273.58
4.7
19.65% -412.22%
SMALL-CAP
1.6B
126.8M
13.84% 14.29%
-26.38
14.01
34.44% -10.05%
1.1B
291.9M
-7.14% -13.41%
-6.57
3.67
52.45% -57.74%
1.0B
795.9M
23.41% -17.93%
-131.34
1.33
8.11% 182.50%
606.7M
236.2M
-6.08% -40.13%
-16.43
2.57
-8.79% -175.19%

Financials for Globus Medical

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue2.5%998974961958942
Gross Profit2.4%743726718719703
Operating Expenses2.1%551540554547491
  S&GA Expenses2.5%421410411408394
  R&D Expenses2.8%1051021009762
Earnings Before Taxes3.6%201194172180223
Net Income0.1%151151138145187
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets3.2%1,9771,9151,9991,9571,911
  Current Assets3.2%920891917865981
    Cash Equivalents-11.0%134151230193362
  Inventory6.2%282266254237234
  Net PPE-1.1%236239228221216
  Goodwill-0.5%182183179180167
Liabilities-1.5%212216213216192
  Current Liabilities-0.5%145146141140123
Shareholder's Equity3.8%1,7641,6991,7851,7411,718
  Retained Earnings4.2%1,1901,1421,2321,1941,179
  Additional Paid-In Capital4.2%606582570554542
Accumulated Depreciation3.4%333322314306301
Shares Outstanding-0.9%101102101--
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-18.9%191235257276280
  Share Based Compensation2.8%3231313129
Cashflow From Investing-23.7%-293.67-237.45-264.72-375.94-251.23
Cashflow From Financing-8.3%-124.58-115.06535482
  Buy Backs-50.0%289578

Risks

What is the probability of a big loss on GMED?

65%


Probability that Globus Medical stock will be more than 20% underwater in next one year

32.7%


Probability that Globus Medical stock will be more than 30% underwater in next one year.

0%


Probability that Globus Medical stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does GMED drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Globus Medical was unfortunately bought at previous high price.

Returns

Cumulative Returns on GMED

17.9%


10-Year Cumulative Returns

15.1%


7-Year Cumulative Returns

14.1%


5-Year Cumulative Returns

8.1%


3-Year Cumulative Returns

What are the long-term rolling returns for GMED?

FIve years rolling returns for Globus Medical.

Which funds bought or sold GMED recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-23
Eagle Bay Advisors LLC
ADDED
25.89
5,169
21,000
0.01%
2022-11-22
CVA Family Office, LLC
UNCHANGED
-
-
-
-%
2022-11-22
Seaport Global Advisors, LLC
ADDED
20.76
78,000
356,000
1.45%
2022-11-22
Capital Impact Advisors, LLC
ADDED
0.29
192,000
1,214,000
1.21%
2022-11-22
IHT Wealth Management, LLC
NEW
-
568,000
568,000
0.04%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
2,485,000
2,485,000
0.03%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-18.07
-883,000
5,872,000
0.01%
2022-11-21
FourThought Financial, LLC
REDUCED
-32.92
-30,000
74,000
0.01%
2022-11-17
Provident Investment Management, Inc.
NEW
-
20,581,000
20,581,000
2.63%
2022-11-17
M&T Bank Corp
ADDED
3.84
801,000
2,508,000
0.01%

1–10 of 47

Latest Funds Activity

Are funds buying GMED calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own GMED

Globus Medical News

Armenian Reporter

Healthcare of Ontario Pension Plan Trust Fund Sells 15573 Shares of Globus Medical, Inc. (NYSE:GMED).27 minutes ago

GuruFocus.com

Zacks Investment Research

GMED Fair Value

Recent SEC filings of Globus Medical

View All Filings
Date Filed Form Type Document
Nov 08, 2022
8-K
Current Report
Nov 08, 2022
10-Q
Quarterly Report

Latest Insider Trading transactions for GMED

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-04-19
Davidar David D
SOLD
-2,458,070
78.034
-31,500
-
2022-04-08
Huller Kelly
SOLD
-188,962
75.585
-2,500
SVP, GC, Corporate Secretary
2022-04-08
Huller Kelly
ACQUIRED
38,350
15.34
2,500
SVP, GC, Corporate Secretary
2022-03-15
TOBIN JAMES R
SOLD
-579,418
65.471
-8,850
-
2022-03-15
TOBIN JAMES R
ACQUIRED
420,005
47.4582
8,850
-
2022-03-10
TOBIN JAMES R
ACQUIRED
435,800
43.58
10,000
-
2022-03-10
TOBIN JAMES R
SOLD
-700,398
70.0398
-10,000
-
2022-03-08
TOBIN JAMES R
SOLD
-322,848
72
-4,484
-
2022-03-08
TOBIN JAMES R
ACQUIRED
195,413
43.58
4,484
-
2021-09-08
Davidar David D
GIFTED
-
-
-2,000
-

1–10 of 50

Daniel T. Scavilla
2400
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

GMED Income Statement

2022-09-30
Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Condensed Consolidated Statements of Operations and Comprehensive Income [Abstract]    
Net sales$ 254,148$ 229,721$ 748,345$ 708,081
Cost of goods sold65,49758,554193,134177,427
Gross profit188,651171,167555,211530,654
Operating expenses:    
Research and development18,70115,85353,50846,324
Selling, general and administrative106,57696,444314,042301,589
Provision for litigation 6052,341511
Amortization of intangibles4,3244,57313,22913,970
Acquisition related costs(652)363(1,832)14,507
Total operating expenses128,949117,838381,288376,901
Operating income/(loss)59,70253,329173,923153,753
Other income/(expense), net    
Interest income/(expense), net3,8992,1058,9187,358
Foreign currency transaction gain/(loss)(2,210)(898)(3,708)(969)
Other income/(expense)74(84)1,770437
Total other income/(expense), net1,7631,1236,9806,826
Income/(loss) before income taxes61,46554,452180,903160,579
Income tax provision14,0347,24140,79926,494
Net income/(loss)47,43147,211140,104134,085
Other comprehensive income/(loss), net of tax:    
Unrealized gain/(loss) on marketable securities(4,380)(991)(18,239)(3,431)
Foreign currency translation gain/(loss)(2,478)(491)(7,215)(3,578)
Total other comprehensive income/(loss), net of tax(6,858)(1,482)(25,454)(7,009)
Comprehensive income/(loss)$ 40,573$ 45,729$ 114,650$ 127,076
Earnings per share:    
Basic$ 0.48$ 0.47$ 1.39$ 1.33
Diluted$ 0.47$ 0.45$ 1.36$ 1.30
Weighted average shares outstanding:    
Basic99,652101,104100,638100,477
Diluted101,417104,418102,789103,430

GMED Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 134,223$ 193,069
Short-term marketable securities271,063250,378
Accounts receivable, net of allowances of $4,284 and $4,962, respectively206,307164,436
Inventories282,408237,001
Prepaid expenses and other current assets23,80318,417
Income taxes receivable2,1971,215
Total current assets920,001864,516
Property and equipment, net of accumulated depreciation of $332,917 and $305,575, respectively236,342221,076
Long-term marketable securities503,965562,475
Intangible assets, net54,05768,660
Goodwill181,774179,708
Other assets35,65436,334
Deferred income taxes44,71924,494
Total assets1,976,5121,957,263
Current liabilities:  
Accounts payable31,97121,955
Accrued expenses88,36191,168
Income taxes payable1,3081,046
Business acquisition liabilities11,32911,770
Deferred revenue12,28612,025
Payable to broker 2,200
Total current liabilities145,255140,164
Business acquisition liabilities, net of current portion52,96558,755
Deferred income taxes1,5784,314
Other liabilities12,60312,642
Total liabilities212,401215,875
Commitments and contingencies (Note 15)
Equity:  
Additional paid-in capital606,352553,787
Accumulated other comprehensive income/(loss)(32,226)(6,772)
Retained earnings1,189,8861,194,272
Total equity1,764,1111,741,388
Total liabilities and equity1,976,5121,957,263
Common Class A [Member]  
Equity:  
Common stock7779
Common Class B [Member]  
Equity:  
Common stock$ 22$ 22